UCB-Pharma SA - Neupro 2 mg/24h, dispositif transdermique
57417
08
Neupro 2 mg/24h
dispositif transdermique
N04BC09
Rotigotine
05.03.2014
Composition
rotigotinum 4.50 mg, silicone adhesive, povidonum K 90, E 223, E 304, E 307, poly(ethylenis terephthalas), ad praeparationem pro 10 cm², cum liberatione 2 mg/24h.